Coltene Holding AG (XSWX:CLTN) 1-Year Sharpe Ratio: -0.56 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CLTN Coltene Holding AG XSWX:CLTN
69 GF Score
Price CHF52.00
GF Value CHF55.12
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Coltene Holding AG 1-Year Sharpe Ratio?

Coltene Holding AG XSWX:CLTN -1.70% 69 1-Year Sharpe Ratio is -0.56 as of Jul. 19, 2026. GuruFocus rates XSWX:CLTN with a GF Score™ of 69/100 and a GF Value™ of CHF55.12 (Fairly Valued). The stock has 3 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-19), Coltene Holding AG's 1-Year Sharpe Ratio is -0.56.

Coltene Holding AG  (XSWX:CLTN) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Coltene Holding AG 1-Year Sharpe Ratio Related Terms

XSWX:CLTN vs ISRG, BDX, MDLN: 1-Year Sharpe Ratio Comparison

For the Medical Instruments & Supplies subindustry, Coltene Holding AG's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coltene Holding AG 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Coltene Holding AG's 1-Year Sharpe Ratio falls into.


XSWX:CLTN
69GF Score
Coltene Holding AG XSWX:CLTN
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coltene Holding AG 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.56 mean?
Coltene Holding AG (XSWX:CLTN) has a 1-Year Sharpe Ratio of -0.56 as of Jul. 19, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Coltene Holding AG and its competitors.
Is Coltene Holding AG's 1-Year Sharpe Ratio too high?
Coltene Holding AG's current 1-Year Sharpe Ratio is -0.56. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's 1-Year Sharpe Ratio compare to ISRG and BDX?
Coltene Holding AG's 1-Year Sharpe Ratio of -0.56 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Coltene Holding AG and its competitors. Coltene Holding AG's current 1-Year Sharpe Ratio is -0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.12, compared to a current price of CHF52.00 — trading 5.7% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.56. Coltene Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current 1-Year Sharpe Ratio is -0.56 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?

Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued. The current stock price of CHF52.00 is trading 5.7% below its estimated GF Value™ of CHF55.12. GuruFocus considers Coltene Holding AG to be Fairly Valued.

Key valuation signals for XSWX:CLTN:

  • 1-Year Sharpe Ratio: -0.56
  • GF Value™: CHF55.12 vs. price of CHF52.00 (5.7% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coltene Holding AG Business Description

Other Exchanges CLTNz:UK0QP7:UKM3Z:Germany
Address Feldwiesenstrasse 20, Altstatten, CHE, 9450
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score

Get the complete analysis for XSWX:CLTN

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF52.00
Price
CHF55.12
GF Value